The Enterprise Value as of September 2024 (TTM) for Algernon Pharmaceuticals Inc. (AGNPF) is 1.49M

According to Algernon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.49M. This represents a change of -24.58% compared to the average of 1.97M of the last 4 quarters.

Algernon Pharmaceuticals Inc. (AGNPF) Historical Enterprise Value (quarterly & annually)

How has AGNPF Enterprise Value performed in the past?

The mean historical Enterprise Value of Algernon Pharmaceuticals Inc. over the last ten years is 9.51M. The current 1.49M Enterprise Value has changed 1.47% with respect to the historical average. Over the past ten years (40 quarters), AGNPF's Enterprise Value was at its highest in in the February 2021 quarter at 57.35M. The Enterprise Value was at its lowest in in the August 2020 quarter at -6081832.85.

Algernon Pharmaceuticals Inc. (AGNPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Algernon Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Algernon Pharmaceuticals Inc. (AGNPF) Average Enterprise Value

How has AGNPF Enterprise Value performed in the past?

The current Enterprise Value of Algernon Pharmaceuticals Inc. (AGNPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Algernon Pharmaceuticals Inc. (AGNPF) Enterprise Value vs. Peers

How is AGNPF’s Enterprise Value compared to its peers?

Algernon Pharmaceuticals Inc.’s Enterprise Value is less than Cellectis S.A. (144.28M), less than Biotron Limited (14.52M), less than Resverlogix Corp. (20.51M), less than Small Pharma Inc. (38.55M), less than Covalon Technologies Ltd. (71.70M), less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (87.12K), less than BioCardia, Inc. (734.10M), less than Wesana Health Holdings Inc. (10.50M), greater than BioVaxys Technology Corp. (417.79K), less than GH Research PLC (14.62M), less than AXIM Biotechnologies, Inc. (329.33M), less than Bioasis Technologies Inc. (8.21M), greater than Mosaic ImmunoEngineering Inc. (398.43K), less than Ceapro Inc. (8.29M), less than null (15.56M),

Build a custom stock screener for Algernon Pharmaceuticals Inc. (AGNPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algernon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algernon Pharmaceuticals Inc. (AGNPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algernon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.